This principle has been extended and refined across diverse targets
En comparacin con los agonistas del receptor GLP-1, los agonistas duales de los receptores GLP-1/GIP pueden proporcionar una reduccin ms significativa de la HbA1c, un mayor beneficio en el control del peso corporal y una mejora ms amplia de diversos parmetros metablicos, aunque la eficacia puede variar segn el medicamento y la poblacin estudiada
No injection, no stack of bottles
Analysis of pooled data To increase the sample size and BW range, five independent experiments totalling 145 rats were pooled into vehicle (V, n = 38), drug (CS + C + S, n = 57) and calorie restriction (WM + PF, n = 50) groups (Extended Data Table 1)
But it's worth noting that the study didn't have a control group, so more rigorous research is still needed